These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 9741698

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner.
    Jong MC, Dahlmans VE, Hofker MH, Havekes LM.
    Biochem J; 1997 Dec 15; 328 ( Pt 3)(Pt 3):745-50. PubMed ID: 9396715
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.
    Medh JD, Fry GL, Bowen SL, Ruben S, Wong H, Chappell DA.
    J Lipid Res; 2000 Nov 15; 41(11):1858-71. PubMed ID: 11060356
    [Abstract] [Full Text] [Related]

  • 5. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.
    Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio LA, Laatsch A, Heeren J.
    J Biol Chem; 2005 Jun 03; 280(22):21553-60. PubMed ID: 15774484
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reduced lipolysis of large apo E-poor very-low-density lipoprotein subfractions from type IV hypertriglyceridemic subjects in vitro and in vivo.
    Evans AJ, Wolfe BM, Strong WL, Huff MW.
    Metabolism; 1993 Jan 03; 42(1):105-15. PubMed ID: 8446037
    [Abstract] [Full Text] [Related]

  • 9. Impact of phosphatidylcholine liposomes on the compositional changes of VLDL during lipoprotein lipase (LPL)-mediated lipolysis.
    Ćwiklińska A, Gliwińska A, Senderowska Z, Kortas-Stempak B, Kuchta A, Dąbkowski K, Jankowski M.
    Chem Phys Lipids; 2016 Feb 03; 195():63-70. PubMed ID: 26756862
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo.
    Rensen PC, van Berkel TJ.
    J Biol Chem; 1996 Jun 21; 271(25):14791-9. PubMed ID: 8662966
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
    Pruneta V, Autran D, Ponsin G, Marcais C, Duvillard L, Verges B, Berthezene F, Moulin P.
    J Clin Endocrinol Metab; 2001 Feb 21; 86(2):797-803. PubMed ID: 11158049
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells.
    Cianflone K, Avramoglu RK, Sawyez C, Huff MW.
    Atherosclerosis; 1996 Feb 21; 120(1-2):101-14. PubMed ID: 8645351
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice.
    Jong MC, Rensen PC, Dahlmans VE, van der Boom H, van Berkel TJ, Havekes LM.
    J Lipid Res; 2001 Oct 21; 42(10):1578-85. PubMed ID: 11590213
    [Abstract] [Full Text] [Related]

  • 15. Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.
    Bharadwaj KG, Hiyama Y, Hu Y, Huggins LA, Ramakrishnan R, Abumrad NA, Shulman GI, Blaner WS, Goldberg IJ.
    J Biol Chem; 2010 Dec 03; 285(49):37976-86. PubMed ID: 20852327
    [Abstract] [Full Text] [Related]

  • 16. In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
    van Barlingen HH, Kock LA, de Man FH, Erkelens DW, de Bruin TW.
    Atherosclerosis; 1996 Mar 03; 121(1):75-84. PubMed ID: 8678926
    [Abstract] [Full Text] [Related]

  • 17. Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transfer.
    Liu G, Excoffon KJ, Wilson JE, McManus BM, Miao L, Benoit P, Duverger N, Branellec D, Denefle P, Hayden MR, Lewis ME.
    Clin Invest Med; 1998 Mar 03; 21(4-5):172-85. PubMed ID: 9800066
    [Abstract] [Full Text] [Related]

  • 18. Lipolytic remnants of human VLDL produced in vitro. Effect of HDL levels in the lipolysis mixtures on the apoCs to apoE ratio and metabolic properties of VLDL core remnants.
    Chung BH, Dashti N.
    J Lipid Res; 2000 Feb 03; 41(2):285-97. PubMed ID: 10681413
    [Abstract] [Full Text] [Related]

  • 19. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE, Li X, van Dijk KW, Havekes LM, Zannis VI.
    Biochemistry; 2003 Aug 26; 42(33):9841-53. PubMed ID: 12924933
    [Abstract] [Full Text] [Related]

  • 20. Enzymes involved in triglyceride hydrolysis.
    Taskinen MR, Kuusi T.
    Baillieres Clin Endocrinol Metab; 1987 Aug 26; 1(3):639-66. PubMed ID: 3330423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.